COMMUNIQUÉS West-GlobeNewswire

-
Carbios presents the results of its Annual General Meeting of 19 June 2025 and the composition of its Board of Directors
20/06/2025 -
CARBIOS présente les résultats de son Assemblée Générale du 19 juin 2025 et la composition de son Conseil d’administration
20/06/2025 -
HealthRX Expands Telehealth Website Experience to Include GLP-1 Weight Loss Solutions, Prescription Access, and 24/7 Wellness Support
20/06/2025 -
Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
20/06/2025 -
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20/06/2025 -
Premier Health Announces a Strategic Review Process to Enhance Shareholder Value
19/06/2025 -
Expanding Access in California: SmartVascular Dx™ Test Now Available Through Major Health Plans
19/06/2025 -
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Share
19/06/2025 -
Labviva Showcases Advanced AI Procurement Tools at the R&D Procurement and Sourcing in Pharma Summit 2025
19/06/2025 -
Anosh Ahmed Drives Major Community Impact Across Chicago Through Healthcare, Education, and Economic Relief Programs
19/06/2025 -
Superlab Suisse to Open New Facility at Campus Biotech in Geneva in January 2026
19/06/2025 -
Kansas State University Veterinary Health Center Adopts Instinct EMR, Retires Legacy System
19/06/2025 -
Unyte Health Launches Sonocea® Enhanced Rest and Restore Protocol™: Revolutionary Approach for Nervous System Regulation
19/06/2025 -
Commure Raises $200 Million in Growth Financing from General Catalyst’s CVF to Accelerate AI-Powered RCM Platform
19/06/2025 -
Theranica to Present Three Real-World Evidence Studies at AHS Scientific Meeting Highlighting the Impact of the Nerivio® REN Wearable on Migraine Treatment
19/06/2025 -
Cannara Biotech to Host Investor Webcast on June 25th, 2025
19/06/2025 -
Cannara Biotech organise une webdiffusion pour les investisseurs le 25 juin 2025
19/06/2025 -
Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in Kidney Transplant Recipients in a Late Breaking Oral Presentation at the World Transplant Congress
19/06/2025 -
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/06/2025
Pages